AHZANTIVE- aflibercept-mrbb_injection, solution
Indication
1 INDICATIONS AND USAGE AHZANTIVE is indicated for the treatment of: 1. 1 Neovascular (Wet) Age-Related Macular Degeneration (AMD) AHZANTIVE is a vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of patients with: Neovascular (Wet) Age-Related Macular Degeneration (AMD) (1. 1) Macular Edema Following Retinal Vein Occlusion (RVO) (1. 2) Diabetic Macular Edema (DME) (1. 3) Diabetic Retinopathy (DR) (1.
Label
Manufacturer
Valorum Biologics Inc